Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolley E Johnson

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Substance Abuse Treatment|January 27, 2011
A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patientsErin L Winstanley, George E Bigelow, Kenneth Silverman, et al.
Journal of Substance Abuse Treatment|August 22, 2006
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadoneDavid C Lott, Eric C Strain, Robert K Brooner, et al.
The American Journal on Addictions|March 15, 2005
Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trialHendrée E Jones, Rolley E Johnson, George E Bigelow, et al.
Therapeutic Drug Monitoring|March 11, 2010
Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomesMarta Concheiro, Hendreé E Jones, Rolley E Johnson, et al.
Archives of Internal Medicine|December 12, 2007
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trialErich F Wedam, George E Bigelow, Rolley E Johnson, et al.
Journal of Addiction Medicine|July 20, 2011
Dosing adjustments in postpartum patients maintained on buprenorphine or methadoneHendrée E Jones, Rolley E Johnson, Kevin E O'Grady, et al.
Journal of Analytical Toxicology|August 9, 2011
Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomesMarta Concheiro, Hendreé E Jones, Rolley E Johnson, et al.
Therapeutic Drug Monitoring|July 12, 2011
Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomesAna de Castro, Hendreé E Jones, Rolley E Johnson, et al.
Drug and Alcohol Dependence|August 4, 2009
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrumentD Andrew Tompkins, George E Bigelow, Joseph A Harrison, et al.
Clinical Chemistry|March 28, 2009
Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatmentSherri L Kacinko, Hendree E Jones, Rolley E Johnson, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Substance Abuse Treatment|January 27, 2011
A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patientsErin L Winstanley, George E Bigelow, Kenneth Silverman, et al.
Journal of Substance Abuse Treatment|August 22, 2006
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadoneDavid C Lott, Eric C Strain, Robert K Brooner, et al.
The American Journal on Addictions|March 15, 2005
Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trialHendrée E Jones, Rolley E Johnson, George E Bigelow, et al.
Therapeutic Drug Monitoring|March 11, 2010
Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomesMarta Concheiro, Hendreé E Jones, Rolley E Johnson, et al.
Archives of Internal Medicine|December 12, 2007
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trialErich F Wedam, George E Bigelow, Rolley E Johnson, et al.
Journal of Addiction Medicine|July 20, 2011
Dosing adjustments in postpartum patients maintained on buprenorphine or methadoneHendrée E Jones, Rolley E Johnson, Kevin E O'Grady, et al.
Journal of Analytical Toxicology|August 9, 2011
Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomesMarta Concheiro, Hendreé E Jones, Rolley E Johnson, et al.
Therapeutic Drug Monitoring|July 12, 2011
Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomesAna de Castro, Hendreé E Jones, Rolley E Johnson, et al.
Drug and Alcohol Dependence|August 4, 2009
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrumentD Andrew Tompkins, George E Bigelow, Joseph A Harrison, et al.
Clinical Chemistry|March 28, 2009
Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatmentSherri L Kacinko, Hendree E Jones, Rolley E Johnson, et al.
Pageof 3